| Year |
Title |
Altmetric |
| 2022
|
Temporal order of clinical and biomarker changes in familial frontotemporal dementia.
Nature Medicine.
28:2194-2206.
2022
|
|
| 2022
|
Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration.
Neurology.
99:E1154-E1167.
2022
|
|
| 2022
|
Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool.
Neurology and Therapy.
11:1085-1100.
2022
|
|
| 2022
|
ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion.
Nature Methods.
19:683-686.
2022
|
|
| 2022
|
14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer’s Disease Mouse Models.
eNeuro.
9.
2022
|
|
| 2022
|
TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model.
Science Translational Medicine.
14.
2022
|
|
| 2022
|
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders.
Cell Reports Medicine.
3.
2022
|
|
| 2022
|
Association of Performance on the Financial Capacity Instrument-Short Form With Brain Amyloid Load and Cortical Thickness in Older Adults.
Neurology: Clinical Practice.
12:113-124.
2022
|
|
| 2022
|
Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures.
Journal of Nuclear Medicine.
63:287-293.
2022
|
|
| 2022
|
Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer’s Mice.
Frontiers in Immunology.
13.
2022
|
|
| 2022
|
Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument-Short Form
2022
|
|
| 2022
|
Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.
Journal of Alzheimer's Disease.
87:489-501.
2022
|
|
| 2021
|
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization.
Scientific Reports.
11.
2021
|
|
| 2021
|
Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood.
Alzheimer's and Dementia.
17:e050692.
2021
|
|
| 2021
|
Developing a functionally valid model of the TREM2-APOE complex to better understand its role in Alzheimer's disease.
Alzheimer's and Dementia.
17:e056092.
2021
|
|
| 2021
|
Gearing up for the future: Exploring facilitators and barriers to inform clinical trial design in frontotemporal lobar degeneration.
Alzheimer's and Dementia.
17:e052495.
2021
|
|
| 2021
|
Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice.
Neurobiology of Disease.
158.
2021
|
|
| 2021
|
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease.
Nature Medicine.
27:1187-1196.
2021
|
|
| 2021
|
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.
Neurology.
96:e2296-e2312.
2021
|
|
| 2021
|
Erratum: ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects (The Journal of clinical investigation (2014) 124 3 (981-999) PII: 149564).
Journal of Clinical Investigation.
131.
2021
|
|
| 2021
|
Functional insights from biophysical study of TREM2 interactions with apoE and Aβ1-42.
Alzheimer's and Dementia.
17:475-488.
2021
|
|
| 2021
|
Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy.
PLoS Genetics.
17.
2021
|
|
| 2021
|
Brain volumetric deficits in MAPT mutation carriers: a multisite study.
Annals of Clinical and Translational Neurology.
8:95-110.
2021
|
|
| 2021
|
Development of a multi-component intervention to promote participation of Black and Latinx individuals in biomedical research..
Journal of Clinical and Translational Science.
5:e134.
2021
|
|
| 2021
|
Racial Differences in Alzheimer's Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.
Journal of Alzheimer's Disease.
79:543-557.
2021
|
|
| 2021
|
Templated α-synuclein inclusion formation is independent of endogenous tau.
eNeuro.
8.
2021
|
|
| 2020
|
Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients.
Annals of Clinical and Translational Neurology.
7:2433-2449.
2020
|
|
| 2020
|
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study.
Nature Communications.
11.
2020
|
|
| 2020
|
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease.
Nature Communications.
11.
2020
|
|
| 2020
|
Alzheimer’s disease risk gene BIN1 induces Tau-dependent network hyperexcitability.
eLife.
9:1-25.
2020
|
|
| 2020
|
Aberrant regulation of a poison exon caused by a non-coding variant in Scn1a-associated epileptic encephalopathy
2020
|
|
| 2020
|
Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials.
Neurology.
94:E2384-E2395.
2020
|
|
| 2020
|
Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases.
American Journal of Human Genetics.
106:632-645.
2020
|
|
| 2020
|
A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent..
Journal of Clinical and Translational Science.
4:345-353.
2020
|
|
| 2020
|
Alzheimer’s disease risk gene BIN1 induces Tau-dependent network hyperexcitability
2020
|
|
| 2020
|
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration.
Nature Medicine.
26:387-397.
2020
|
|
| 2020
|
Human tau pathology transmits glial tau aggregates in the absence of neuronal tau.
Journal of Experimental Medicine.
217.
2020
|
|
| 2020
|
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity.
Neurobiology of Disease.
134.
2020
|
|
| 2020
|
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients with Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.
JAMA Neurology.
77:215-224.
2020
|
|
| 2020
|
β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade.
Science Translational Medicine.
12.
2020
|
|
| 2020
|
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration.
Alzheimer's and Dementia.
16:91-105.
2020
|
|
| 2020
|
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.
Alzheimer's and Dementia.
16:11-21.
2020
|
|
| 2020
|
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint..
Alzheimer's and Dementia.
16:11-21.
2020
|
|
| 2020
|
Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration.
Alzheimer's and Dementia.
16:49-59.
2020
|
|
| 2020
|
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.
Alzheimer's and Dementia.
16:60-70.
2020
|
|
| 2020
|
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.
Alzheimer's and Dementia.
16:118-130.
2020
|
|
| 2020
|
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.
Alzheimer's and Dementia.
16:37-48.
2020
|
|
| 2020
|
Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.
Alzheimer's and Dementia.
16:79-90.
2020
|
|
| 2020
|
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
Alzheimer's and Dementia.
16:106-117.
2020
|
|
| 2019
|
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
Acta Neuropathologica Communications.
7.
2019
|
|
| 2019
|
A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data.
Scientific Reports.
9.
2019
|
|
| 2019
|
A blood-based signature of cerebrospinal fluid Aβ 1–42 status.
Scientific Reports.
9.
2019
|
|
| 2019
|
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
2019
|
|
| 2019
|
Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways.
Scientific Reports.
9.
2019
|
|
| 2019
|
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification.
Scientific Reports.
9.
2019
|
|
| 2019
|
Non-coding variability at the APOE locus contributes to the Alzheimer’s risk.
Nature Communications.
10.
2019
|
|
| 2019
|
Nonlinear Z-score modeling for improved detection of cognitive abnormality
2019
|
|
| 2019
|
Predicting Alzheimer’s disease progression using multi-modal deep learning approach.
Scientific Reports.
9.
2019
|
|
| 2019
|
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.
Scientific Reports.
9.
2019
|
|
| 2019
|
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
Nature Communications.
10.
2019
|
|
| 2019
|
Neurodegenerative Disease–Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain.
Frontiers in Neurology.
10.
2019
|
|
| 2019
|
Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis.
Neuron.
104:458-470.e5.
2019
|
|
| 2019
|
Non-Coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases
2019
|
|
| 2019
|
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2).
Nature Genetics.
51:1423-1424.
2019
|
|
| 2019
|
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia.
Molecular Neurobiology.
56:4916-4924.
2019
|
|
| 2019
|
Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Workflow for Research and Clinical Brain PET Applications
2019
|
|
| 2019
|
Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders.
Parkinsonism and Related Disorders.
61:77-81.
2019
|
|
| 2019
|
Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice.
Neurobiology of Disease.
124:152-162.
2019
|
|
| 2019
|
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Nature Genetics.
51:414-430.
2019
|
|
| 2019
|
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Parkinsonism and Related Disorders.
60:138-145.
2019
|
|
| 2019
|
Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications.
Journal of Alzheimer's Disease.
70:1241-1257.
2019
|
|
| 2019
|
Genome sequencing for early-onset or atypical dementia: High diagnostic yield and frequent observation of multiple contributory alleles.
Cold Spring Harbor molecular case studies.
5.
2019
|
|
| 2018
|
Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states.
Scientific Reports.
8.
2018
|
|
| 2018
|
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease.
Scientific Reports.
8.
2018
|
|
| 2018
|
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images.
Scientific Reports.
8.
2018
|
|
| 2018
|
Sex-specific genetic predictors of Alzheimer’s disease biomarkers.
Acta Neuropathologica.
136:857-872.
2018
|
|
| 2018
|
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.
Nature Communications.
9.
2018
|
|
| 2018
|
Sex-specific association of apolipoprotein e with cerebrospinal fluid levels of tau.
JAMA Neurology.
75:989-998.
2018
|
|
| 2018
|
Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
Molecular Neurodegeneration.
13.
2018
|
|
| 2018
|
Shared Functions of Perirhinal and Parahippocampal Cortices: Implications for Cognitive Aging.
Trends in Neurosciences.
41:349-359.
2018
|
|
| 2018
|
18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery..
Anesthesiology.
128:728-744.
2018
|
|
| 2018
|
Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis
2018
|
|
| 2018
|
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease
2018
|
|
| 2017
|
Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features.
Scientific Reports.
7.
2017
|
|
| 2017
|
Genetic influences on cognition in progressive supranuclear palsy.
Movement Disorders.
32:1764-1771.
2017
|
|
| 2017
|
Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty.
Scientific Reports.
7.
2017
|
|
| 2017
|
18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.
Annals of Neurology.
82:622-634.
2017
|
|
| 2017
|
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
Nature Genetics.
49:1373-1384.
2017
|
|
| 2017
|
Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
Alzheimer's and Dementia.
13:727-738.
2017
|
|
| 2017
|
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects.
Journal of Neural Transmission.
124:721-738.
2017
|
|
| 2017
|
Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease.
JAMA Neurology.
74:557-566.
2017
|
|
| 2017
|
Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia
2017
|
|
| 2017
|
Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.
Scientific Reports.
7.
2017
|
|
| 2017
|
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.
Neurobiology of Aging.
49:216.e7.
2017
|
|
| 2016
|
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.
Annals of Neurology.
80:858-870.
2016
|
|
| 2016
|
Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.
Movement Disorders.
31:1574-1577.
2016
|
|
| 2016
|
Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
Parkinsonism and Related Disorders.
28:29-35.
2016
|
|
| 2016
|
Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.
Parkinsonism and Related Disorders.
28:41-48.
2016
|
|
| 2016
|
Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test.
Genes, Brain and Behavior.
15:588-603.
2016
|
|
| 2016
|
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
Nature Communications.
7.
2016
|
|
| 2016
|
Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults.
JAMA Neurology.
73:721-732.
2016
|
|
| 2016
|
Assessment of the genetic variance of late-onset Alzheimer's disease.
Neurobiology of Aging.
41:200.e13-200.e20.
2016
|
|
| 2016
|
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.
Movement Disorders.
31:742-747.
2016
|
|
| 2016
|
Alzheimer's disease risk polymorphisms regulate gene expression in the ZCWPW1 and the CELF1 loci.
PLoS One.
11.
2016
|
|
| 2016
|
A novel Alzheimer disease locus located near the gene encoding tau protein.
Molecular Psychiatry.
21:108-117.
2016
|
|
| 2015
|
Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.
Alzheimer's and Dementia.
11:1439-1451.
2015
|
|
| 2015
|
The Alzheimer’s disease risk factor CD2AP maintains blood–brain barrier integrity.
Human Molecular Genetics.
24:6667-6674.
2015
|
|
| 2015
|
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease
2015
|
|
| 2015
|
Association of long runs of homozygosity with Alzheimer disease among African American individuals.
JAMA Neurology.
72:1313-1323.
2015
|
|
| 2015
|
O3‐06‐01: Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.
Alzheimer's and Dementia.
11:p230-p230.
2015
|
|
| 2015
|
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.
PLoS Medicine.
12.
2015
|
|
| 2015
|
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.
Nature Communications.
6.
2015
|
|
| 2015
|
Effects of exercise on progranulin levels and gliosis in progranulin-insufficient mice.
eNeuro.
2.
2015
|
|
| 2015
|
DNA methylation slows effects of C9orf72 mutations.
Neurology.
84:1616-1617.
2015
|
|
| 2015
|
Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease
2015
|
|
| 2015
|
Rarity of the alzheimer disease-protective APP A673T variant in the United States.
JAMA Neurology.
72:209-216.
2015
|
|
| 2015
|
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
Blood.
125:591-599.
2015
|
|
| 2015
|
Noradrenergic dysfunction in Alzheimer's disease.
Frontiers in Neuroscience.
9.
2015
|
|
| 2014
|
AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (bret) assays for identification of Tau-Fyn sh3 interaction inhibitors for Alzheimer disease.
SLAS Discovery.
19:1338-1349.
2014
|
|
| 2014
|
Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia
2014
|
|
| 2014
|
MicroRNA-124 modulates social behavior in frontotemporal dementia.
Nature Medicine.
20:1381-1383.
2014
|
|
| 2014
|
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: A genome-wide association study.
JAMA Neurology.
71:1394-1404.
2014
|
|
| 2014
|
Seizure resistance without parkinsonism in aged mice after tau reduction.
Neurobiology of Aging.
35:2617-2624.
2014
|
|
| 2014
|
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
Journal of Clinical Investigation.
124:981-999.
2014
|
|
| 2014
|
Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial.
Lancet Neurology.
13:676-685.
2014
|
|
| 2014
|
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.
Journal of Experimental Medicine.
211:1937-1945.
2014
|
|
| 2014
|
The dendritic hypothesis for Alzheimer's disease pathophysiology.
Brain Research Bulletin.
103:18-28.
2014
|
|
| 2013
|
Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice
2013
|
|
| 2013
|
Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in alzheimer's disease.
Journal of Cell Science.
126:1278-1286.
2013
|
|
| 2013
|
Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development.
Alzheimer's and Dementia.
9:176-188.
2013
|
|
| 2013
|
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier).
Alzheimer's and Dementia.
9:189-198.
2013
|
|
| 2012
|
Challenges and opportunities for characterizing cognitive aging across species.
Frontiers in Aging Neuroscience.
4.
2012
|
|
| 2012
|
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis.
Nature Genetics.
44:1349-1354.
2012
|
|
| 2012
|
Mouse models of frontotemporal dementia.
Annals of Neurology.
72:837-849.
2012
|
|
| 2012
|
Usp14 Deficiency Increases Tau Phosphorylation without Altering Tau Degradation or Causing Tau-Dependent Deficits.
PLoS One.
7.
2012
|
|
| 2012
|
Novel late-onset Alzheimer disease loci variants associate with brain gene expression..
Neurology.
79:221-228.
2012
|
|
| 2012
|
Mouse models of Alzheimer's disease.
Brain Research Bulletin.
88:3-12.
2012
|
|
| 2012
|
Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants..
PLoS Genetics.
8:e1002707.
2012
|
|
| 2012
|
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Human Molecular Genetics.
21:3500-3512.
2012
|
|
| 2011
|
Geriatric epilepsy: Research and clinical directions for the future.
Epilepsy and Behavior.
22:103-111.
2011
|
|
| 2011
|
Contemporary approaches to Alzheimer's disease and frontotemporal dementia..
Methods in Molecular Biology.
670:1-9.
2011
|
|
| 2011
|
Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling..
Methods in Molecular Biology.
670:245-262.
2011
|
|
| 2011
|
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Nature Genetics.
43:436-443.
2011
|
|
| 2011
|
Amyloid-β/fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of alzheimer's disease
2011
|
|
| 2011
|
Contemporary approaches to Alzheimer's disease and frontotemporal dementia.
Methods in Molecular Biology.
670:1-9.
2011
|
|
| 2011
|
Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: Depletion of calcium-dependent proteins and inhibitory hippocampal remodeling.
Methods in Molecular Biology.
670:245-262.
2011
|
|
| 2011
|
Step-by-step in situ hybridization method for localizing gene expression changes in the brain.
Methods in Molecular Biology.
670:207-230.
2011
|
|
| 2010
|
Beyond diagnosis: What biomarkers are teaching us about the "bio"logy of Alzheimer disease.
Annals of Neurology.
67:283-285.
2010
|
|
| 2009
|
Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease
2009
|
|
| 2008
|
Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease
2008
|
|
| 2008
|
Abnormal social behaviors in mice lacking Fgf17.
Genes, Brain and Behavior.
7:344-354.
2008
|
|
| 2007
|
Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease.
Neuron.
55:697-711.
2007
|
|
| 2007
|
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model.
Science.
316:750-754.
2007
|
|
| 2006
|
100 Years and counting: Prospects for defeating Alzheimer's disease.
Science.
314:781-784.
2006
|
|
| 2006
|
Frontotemporal demetia.
Current Neurology and Neuroscience Reports.
6:481-489.
2006
|
|
| 2006
|
Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease.
Neuron.
51:703-714.
2006
|
|
| 2005
|
Frontotemporal dementia progresses to death faster than Alzheimer disease.
Neurology.
65:719-725.
2005
|
|
| 2005
|
Frontotemporal lobar degeneration: Demographic characteristics of 353 patients.
JAMA Neurology.
62:925-930.
2005
|
|
| 2003
|
Polyneuropathy following gastric bypass surgery [6].
American Journal of Medicine.
115:679-680.
2003
|
|
| 2001
|
Memory-forming chemical reactions.
Reviews in the Neurosciences.
12:41-50.
2001
|
|
| 2000
|
MAPK regulation of gene expression in the central nervous system.
Acta Neurobiologiae Experimentalis.
60:377-394.
2000
|
|
| 1999
|
A biochemical blueprint for long-term memory.
Learning and Memory.
6:381-388.
1999
|
|
| 1999
|
The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus
1999
|
|
| 1998
|
Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation
1998
|
|
| 1998
|
A role for superoxide in protein kinase C activation and induction of long-term potentiation.
Journal of Biological Chemistry.
273:4516-4522.
1998
|
|
| 1998
|
Protected-site phosphorylation of protein kinase C in hippocampal long- term potentiation.
Journal of Neurochemistry.
71:1075-1085.
1998
|
|
| 1996
|
Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation.
Journal of Biological Chemistry.
271:30436-30441.
1996
|
|
| 1996
|
A biochemist's view of long-term potentiation.
Learning and Memory.
3:1-24.
1996
|
|
| 1995
|
Regulation of adenylyl cyclase in LTP.
Behavioral and Brain Sciences.
18:485-486.
1995
|
|
| 1995
|
Regulation of adenylyl cyclase in LTP.
Behavioral and Brain Sciences.
18:485-486.
1995
|
|
| 1992
|
Ca2+-induced persistent protein kinase C activation in rat hippocampal homogenates.
Journal of Receptors and Signal Transduction.
14:109-126.
1992
|
|
| 1988
|
Identification of an insulin-like factor in astrocyte conditioned medium.
Brain Research.
460:60-67.
1988
|
|
